People who take bisphosphonates for osteoporosis may be at risk for serious atrial fibrillation (AF), or irregular heartbeats, according to a new study. The research, presented at CHEST 2008, the 74th annual international scientific assembly of the American College of Chest Physicians (ACCP), shows that people taking alendronate or zoledronic acid, two common medications to prevent or slow the occurrence of osteoporosis, were significantly more likely to experience serious AF, including hospitalisation or death, compared with placebo...
- Osteoporosis drugs increase risk for heart problemsTue, 28 Oct 2008, 10:17:54 EDT
- Statins show promise for blood clot preventionTue, 28 Oct 2008, 11:58:31 EDT
- Commonly prescribed osteoporosis drug associated with very low risk of serious jaw diseaseMon, 14 Feb 2011, 12:03:22 EST
- Benefits of osteoporosis treatments outweigh possible risk of rare femoral fracturesWed, 24 Mar 2010, 18:18:12 EDT
- Link between widely used osteoporosis drugs and heart problems probedMon, 6 Apr 2009, 15:51:06 EDT